1985
DOI: 10.1111/j.1348-0421.1985.tb00837.x
|View full text |Cite
|
Sign up to set email alerts
|

Drug‐Resistant Mutants of Herpes Simplex Virus Type 2 with a Mutator or Antimutator Phenotype

Abstract: The mutator or antimutator phenotype has been extensively studied in T4 phage and Escherichia coli (1, 2, 13), and these phenotypes have been shown to be genetically related to structural genes for DNA polymerase and other replication proteins (3, 6). In eukaryotic systems, it has been reported that an aphidicolinresistant Chinese hamster cell mutant which has an altered DNA polymerase exhibits an increase in the rate of spontaneous mutagenesis (8). In addition, Hall et al (4) have shown that phosphonoacetic a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
1

Year Published

1987
1987
2019
2019

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 16 publications
(11 reference statements)
1
6
1
Order By: Relevance
“…Furthermore, the A498V and A498T mutations exhibited, respectively, moderate and acute hypersensitivity to PAA or 9-β-D-arabinofuranosyladenine (AraA), and moderate hypersensitivity to 1-β-D-arabinofuranosylcytosine (AraC). While it is interesting that resistance to a dCTP competitor, aphidicolin, conferred increased sensitivity to, and thus likely altered affinity for, the nucleotide analogues AraA and AraC, previous studies in Herpes simplex virus and other systems have reported similar trends (Gibbs et al, 1988; Hall et al, 1989; Matsumoto et al, 1990; Nishiyama et al, 1985). Similarly, this inverse relationship between aphidicolin and PAA / nucleoside analogue resistance and sensitivity appears to hold true for the three aforementioned mutations conferring PAA resistance: C356T, G372D, G380S.…”
Section: : the Dna Polymerase: Genetic Dissectionmentioning
confidence: 84%
“…Furthermore, the A498V and A498T mutations exhibited, respectively, moderate and acute hypersensitivity to PAA or 9-β-D-arabinofuranosyladenine (AraA), and moderate hypersensitivity to 1-β-D-arabinofuranosylcytosine (AraC). While it is interesting that resistance to a dCTP competitor, aphidicolin, conferred increased sensitivity to, and thus likely altered affinity for, the nucleotide analogues AraA and AraC, previous studies in Herpes simplex virus and other systems have reported similar trends (Gibbs et al, 1988; Hall et al, 1989; Matsumoto et al, 1990; Nishiyama et al, 1985). Similarly, this inverse relationship between aphidicolin and PAA / nucleoside analogue resistance and sensitivity appears to hold true for the three aforementioned mutations conferring PAA resistance: C356T, G372D, G380S.…”
Section: : the Dna Polymerase: Genetic Dissectionmentioning
confidence: 84%
“…; cells were harvested at 3 or 4 days p.i. sometimes associated with altered polymerase fidelity (17,18,20,28,32). In this context, the Aphr isolates were investigated for alterations in mutation rate by assaying the spontaneous frequency of viral mutants resistant to PAA, IBT, and rifampin.…”
Section: Dose-dependent Inhibition Of Vaccinia Virus Replication Bymentioning
confidence: 99%
“…Viral DNA polymerases from wild type herpes simplex virus type 2 (HSV-2) and from virus resistant to phosphonoacetic acid (PAAr) or to aphidicolin (Aphr) were purified from infected cells, as described by Nishiyama et al (9), as have the mutator (Aphr) and antimutator (PAAr) viral phenotypes (10).…”
Section: Enzymesmentioning
confidence: 99%